Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
THNR
18
HOLDINGS
17%
ALSO IN IDNA
IDNA
44
HOLDINGS
8%
ALSO IN THNR
SECTOR DRIFT (THNR minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 8.3% | 5.1% | 5.1% |
|
MERCK & CO. INC. | 5.6% | 4.3% | 4.3% |
 |
ROCHE HOLDING LTD | 5.2% | 3.8% | 3.8% |
THNR Overweight Relative to IDNA
|
ELI LILLY & CO | 16.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 10.3% |
|
AMGEN INC | 7.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 7.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.2% |
|
PFIZER INC | 4.7% |
|
ABBVIE INC | 4.7% |
 |
INNOVENT BIOLOGICS, INC. | 4.4% |
|
SHIONOGI & CO LTD | 4.3% |
 |
CHINA PHARMACEUTICAL GROUP | 3.6% |
THNR Underweight Relative to IDNA
|
REVOLUTION MEDICINES, INC. | -6.1% |
|
CELCUITY INC. | -5.7% |
|
INCYTE CORP | -4.9% |
|
GENMAB A/S | -4.6% |
|
ASTRAZENECA PLC | -4.1% |
|
GSK PLC | -3.7% |
|
ARCELLX, INC. | -3.4% |
|
EXELIXIS INC | -3.3% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
SANOFI-AVENTIS | -3.2% |